Cardiovascular Health Program: Advanced Testing and Plasma Exchange
We help adults who worry about cholesterol, inflammation, and family history take action with advanced testing and a planned series of plasma exchange sessions, so they can watch their own numbers change, before and after.
For adults with elevated cardiovascular risk factors or a family history of early heart disease. This Program does not replace statins or blood pressure management. A clinical review comes first.
- Same labs before and after
- Clinic Director: Dr. David George
- Scottsdale, Arizona
- ApoB as a risk marker: Established
- Plasma exchange for cardiovascular risk: Limited
Visit or call the clinic
- 8090 N. 85th Way, Suite 100, Scottsdale, AZ 85258
- (623) 294-5577
- Monday to Friday, 9 a.m. to 5 p.m.



At a glance
- What this is
- Advanced lipid and inflammation testing, before and after a planned series of plasma exchange sessions.
- Who it is for
- Adults with elevated cardiovascular risk factors or a family history of early heart disease.
- Evidence
- ApoB as a risk marker: Established. Plasma exchange for cardiovascular risk: Limited.
- Next step
- A clinical review comes first. Talk to our clinical team: call (623) 294-5577.
Who this Program is for
- I’m doing the right things and want to see more.
- I have a family history and want clearer numbers.
- I want to be more proactive about my heart health.
Many people who come to us are already doing the right things: watching their diet, staying active, maybe already on a statin. This Program builds on that. It gives you a real, measured answer to the question those efforts are supposed to be solving: are my numbers actually moving?
How the Program works
Clearegen starts with a baseline panel, runs a planned series of sessions, re-tests with the same panel, and gives you a plain-language report of what changed.
From first conversation to seeing your numbers change
The Program, in order
- 1. Clinical conversationYour history, your goals, and your current plan
- 2. Baseline panelFocused panel included; Expanded panel is an additional fee
- 3. ClearCycle™ sessionsA planned series of plasma exchange sessions
- 4. Re-testSame panel, same lab, to see what changed
- 5. Plain-language reportBefore and after, side by side. Sample report: illustrative, not a patient result.
- 6. Decide what comes nextWe review the change with you and plan next steps. Medication changes stay with your prescriber.
Keep taking your medicines as prescribed. Medication decisions stay with your prescriber.
What we test, before and after
Many lipid experts now use ApoB as a more precise guide than LDL cholesterol.¹
| Marker | What it reflects |
|---|---|
| ApoB | Count of cholesterol-carrying particles that can enter artery walls |
| LDL cholesterol (LDL-C), total cholesterol, non-HDL-C, HDL-C, triglycerides (the full lipid panel) | Standard cholesterol and lipid values, including the LDL-C that statins, ezetimibe, and PCSK9 inhibitors are prescribed to lower |
| hs-CRP | Background inflammation |
| Advanced lipid panel (particle number and size) | A finer picture of the particles |
| Homocysteine | An amino acid linked to vascular risk |
| Fibrinogen | A clotting protein that also rises with inflammation |
| Coronary artery calcium score or CT angiography (optional) | Imaging of plaque. Bring recent results if you have them. |
How is plasma exchange believed to work for cardiovascular health?
Evidence status: Emerging (mechanism). The mechanism is a rationale for why numbers may change for a time. It is not evidence that risk falls.
- Blood out.
- Plasma separated and replaced.
- Blood returned.
Expected pattern across a series: each session starts from a lower level than the one before
Illustrative sketch, not patient data. An effect on heart attack or stroke risk has not been shown.
- ApoB particlesCarry cholesterol in the blood
- Inflammatory proteinshs-CRP and fibrinogen
Level in blood across a series (illustrative). The dashed line is the starting level. No values are shown.
Starting level
Re-test
- Session 1 Dips, then slowly rises
- Session 2 Goes lower
- Session 3 Lower again
A reading taken right after a session reflects what was removed, not your new baseline.
What happens in a session. Blood is drawn, the liquid part (plasma) is separated from the blood cells, and the plasma is replaced with a sterile replacement fluid, usually albumin, before the cells are returned. Part of the plasma, and what it carries, is removed and replaced.
What plasma carries that matters for the heart. Cholesterol travels in particles, each with one ApoB protein, so ApoB counts those particles. Inflammatory proteins such as hs-CRP and fibrinogen also circulate in plasma. When plasma is removed, some of each is removed with it.
What researchers have measured. In studies of people with established illness, a single plasma exchange lowered inflammatory and heart-strain markers such as CRP right away, and those markers were found in the plasma that was removed, which confirms that the effect is removal.⁶ Researchers advise caution when reading these markers soon after a session. In a small study without a control group, adults with metabolic syndrome had a lower CRP after four low-volume sessions.⁷ Whether any of these changes last, or lower the risk of a heart attack or stroke, has not been shown.
What we expect to see, and for how long. These numbers are expected to fall after a session and then rise again as the body makes more. That is why Clearegen plans a series of sessions and re-tests with the same panel.
After an exchange, the level of a substance rebounds through resynthesis and movement back into the blood, which is why sessions are repeated.⁹ Whether lasting changes in inflammatory signaling follow is not settled.⁸
Why timing matters for your report. A blood test taken right after a session partly reflects what was just removed. We therefore compare your baseline with a re-test taken at a set time after your series, and we tell you when each sample was drawn.
How this fits with your medicines. Lower levels are expected to support the effect of prescribed medicines such as statins, ezetimibe, and PCSK9 inhibitors. Plasma exchange is not a standalone therapy.*
*Plasma exchange is supplemental to evidence-based medical management.
What it does not do. Plasma exchange is not selective, so it also removes helpful proteins, which the body replaces. It does not do what daily medicines and a lifestyle plan do, which keep working every day. A change in a number does not by itself mean lower risk of a heart attack or stroke.
What the evidence shows, and what it does not
Established. ApoB is a recognized marker of cardiovascular risk. Many lipid experts now use ApoB as a more precise guide than LDL cholesterol.¹
Studied in other settings. Lipoprotein apheresis, a selective cousin of plasma exchange, is used for severe inherited cholesterol disorders and for established heart disease. In large registries, people had fewer cardiovascular events after starting it than before, though these were observational studies without a control group.²,³,⁵ In severe familial hypercholesterolemia, plasma exchange has a recognized supporting role.⁴
What plasma exchange is believed to do. Plasma exchange removes part of the plasma, including some cholesterol-carrying particles and inflammatory proteins, and replaces it. Those numbers are expected to fall for a time and then rise again as the body makes more. Plasma exchange is not selective, so it also removes helpful proteins.
What has not been shown. We are not aware of trials showing that plasma exchange lowers the risk of heart attack or stroke in people with elevated risk factors. This Program does not claim it does. It measures your numbers before and after, so you can see what changed.
What researchers say. A 2025 review of plasma exchange across many conditions describes how it removes circulating proteins, antibodies, and inflammatory molecules, and notes that effects are often temporary. Triglycerides typically recover within about a week, and LDL cholesterol returns toward baseline over weeks to months. The authors say larger trials are needed for most uses.⁸
What happens in a ClearCycle™
ClearCycle™ is Clearegen’s planned series of plasma exchange sessions in Blood Rehabilitation. Plasma exchange removes part of the plasma, including some cholesterol-carrying particles and inflammatory proteins. These numbers are expected to fall for a time and can rise again.
The same panel is checked before and after. A short-term change should not be assumed durable without repeat testing.
Your clinical team
Your care comes from a dedicated blood rehabilitation team of experienced registered nurses, nurse practitioners and clinicians. You will meet more than one of us, and one dedicated registered nurse stays with you, one-on-one, for the entire procedure.
The team is led by our Clinic Director, David George, FNP-BC:
- Board-certified family nurse practitioner (FNP-BC)
- Trained and experienced in therapeutic plasma exchange
- Member, American Society for Apheresis (ASFA)
Clinical review of each person’s labs, history, and current plan comes before any protocol is planned.
Meet the people who would look after you. Talk to our clinical team.
Frequently asked questions
Will this replace my statin?
No. Keep taking your medicines as prescribed. Medication decisions stay with your prescriber.
What is ApoB, and why test it?
A count of the cholesterol-carrying particles that can enter artery walls. Many lipid experts use it as a more precise guide than LDL cholesterol, according to the National Lipid Association expert consensus.¹
Does plasma exchange lower cholesterol?
It is believed to lower ApoB and LDL-C for a time, because it removes part of the plasma. Levels can rise again as the body makes more, which is why we re-test, and why we recommend that TPE is performed in conjunction with other measures to maintain healthy levels.
Is plasma exchange an approved treatment for heart disease or high cholesterol?
No. It is not an approved way to lower cardiovascular risk. It has a recognized supporting role in severe familial hypercholesterolemia. We do not claim it lowers the risk of heart attack or stroke.
How is this different from lipoprotein apheresis?
Lipoprotein apheresis selectively removes LDL and is used for severe inherited high cholesterol and for established heart disease. Plasma exchange is not selective. People who may need apheresis should stay with their lipid or cardiology team.
Who may be considered?
Adults with elevated risk factors or a family history of early heart disease, after review by our clinical team.
What does a series look like, and when do you re-test?
A planned series of sessions followed by a re-test with the same panel.
What are the risks?
TPE is widely used, and serious complications are uncommon, but it is not risk-free. Possible effects include tingling or cramping (from the anticoagulant lowering calcium), low blood pressure, lightheadedness, bruising or irritation at the IV site, and allergic reactions to replacement fluids. TPE also removes helpful proteins along with plasma, including antibodies and clotting factors, for a time. Rare risks include infection and bleeding. Tell the team about every medicine and supplement you take, especially blood thinners, ACE inhibitors and any drug that binds to plasma proteins, because plasma exchange can affect their levels and timing should be coordinated with the prescriber. Blood tests drawn soon after a session can read low for markers that the exchange removes, so tell any clinician or emergency team about a recent session.
Questions about the Cardiovascular Health Program?
Our clinical team will talk through your current plan, explain what we would measure and why, and tell you honestly whether this Program may be a fit. There is no pressure to decide.
Helpful to have ready: your most recent lipid panel, a list of your medicines, and any recent imaging.
References
- Soffer DE, Marston NA, Maki KC, et al. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: an expert clinical consensus from the National Lipid Association. J Clin Lipidol. 2024;18(5):e647-e663. doi:10.1016/j.jacl.2024.08.013
- Schettler VJJ, Neumann CL, Peter C, et al. The German Lipoprotein Apheresis Registry (GLAR)—almost 5 years on. Clin Res Cardiol Suppl. 2017;12(suppl 1):44-49. doi:10.1007/s11789-017-0089-9
- Nugent AK, Gray JV, Gorby LK, Moriarty PM. Lipoprotein apheresis: first FDA indicated treatment for an inherited lipoprotein particle. J Clin Cardiol. 2020;1(1):16-21. doi:10.33696/cardiology.1.002
- Connelly-Smith L, Alquist CR, Aqui NA, et al. Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue. J Clin Apher. 2023;38(2):77-278. doi:10.1002/jca.22043
- Gianos E, Duell PB, Toth PP, et al. Lipoprotein apheresis: utility, outcomes, and implementation in clinical practice: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2024;44(12):e304-e321. doi:10.1161/ATV.0000000000000177
- Tutarel O, Golla P, Beutel G, et al. Therapeutic plasma exchange decreases levels of routinely used cardiac and inflammatory biomarkers. PLoS One. 2012;7(6):e38573. doi:10.1371/journal.pone.0038573
- Slavic V, Antunovic T, Randjelovic D, Terzic Stanic N, Boljevic J. Therapeutic role of low-volume plasma exchange in modulating lipopolysaccharides-binding protein and inflammatory pathways in metabolic syndrome. Arch Med Sci Atheroscler Dis. 2026;11(1):17-23. doi:10.5114/amsad/216575
- Rony RMIK, Shokrani A, Malhi NK, et al. Therapeutic plasma exchange: current and emerging applications to mitigate cellular signaling in disease. Biomolecules. 2025;15(7):1000. doi:10.3390/biom15071000
- Altobelli C, Anastasio P, Cerrone A, et al. Therapeutic plasmapheresis: a revision of literature. Kidney Blood Press Res. 2023;48(1):66-78. doi:10.1159/000528556
The Cardiovascular Health Program is an elective wellness service and is not a substitute for statin therapy, blood pressure management, or ongoing cardiology care. It is not intended to diagnose, treat, cure, or prevent any disease.

Questions worth asking any clinic, including ours.
Before you decide, ask us these. We’ll answer them plainly.
- What is the evidence for this use of TPE, and how strong is it?
- What will my Focused panel measure, what would an Expanded panel add, and how will we know what changed?
- What are the risks, and who should not have this procedure?
- What will it cost in total? (The Focused panel is included; the Expanded panel is an additional fee.)
- How will my own physician or clinician be kept informed?
Call us or send a request online, and our clinical team will answer your questions and set up a consultation.
Visit or call the clinic
Blood Rehabilitation Centers, Scottsdale, Arizona. Call us or send a request online, and our clinical team will answer your questions and set up a consultation.
Call (623) 294-5577- 8090 N. 85th Way, Suite 100, Scottsdale, AZ 85258
- Monday to Friday, 9 a.m. to 5 p.m.
What would you like to understand?
Browse all pages
- Home
- Blood Rehabilitation
- How We Prove It
- Programs
- The Vitality Cascade
- Membership
- TPE / Plasmapheresis
- TPE Fees & Packages
- How ClearCycle™ TPE Works
- The Evidence Behind TPE
- TPE Patient Experience
- eBoo
- EBO2 Fees & Packages
- How EBO2 Works
- EBO2 Patient Experience
- Safety & Standards
- Dr. David George
- Team
- For referring clinicians
- Contact Us in Scottsdale
- Frequently Asked Questions
- Privacy
- Terms & Conditions
- Cookie Policy
- Accessibility
- TPE for Biological Age
- TPE for Autoimmune & Chronic Inflammatory Conditions
- TPE for Cardiovascular Health
- TPE for Brain Health & Cognitive Function
- TPE for Environmental Exposure: Mold, Microplastics & Environmental Toxins
- TPE for Women’s Health
- Cardiovascular Health Program
- Biological Age
- Brain Health
- Autoimmune
- Environmental Exposure Program
- Women’s Health
- Performance Blood Health
- AMBAR trial summary